Pharmosa Biopharm Inc. (6875.TWO)
TWD 47.0
(-9.96%)
TWD 47.0
(-9.96%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.33 Billion TWD | 66.84% |
| 2022 | 799.36 Million TWD | 36.33% |
| 2021 | 586.36 Million TWD | 7.93% |
| 2020 | 543.27 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.26 Billion TWD | 69.97% |
| 2024 Q2 | 2.21 Billion TWD | -2.2% |
| 2023 Q3 | 1.42 Billion TWD | 94.61% |
| 2023 Q2 | 732.5 Million TWD | 0.0% |
| 2023 FY | 1.33 Billion TWD | 66.84% |
| 2023 Q1 | - TWD | -100.0% |
| 2023 Q4 | 1.33 Billion TWD | -6.45% |
| 2022 Q4 | 799.36 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -941.526% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 54.026% |
| Level Biotechnology Inc. | 822.67 Million TWD | -62.111% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -100.631% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -143.034% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 65.751% |
| GlycoNex Incorporation | 1.55 Billion TWD | 14.114% |
| VBI | 452.1 Million TWD | -194.987% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -13.391% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -78.159% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -252.478% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -17.621% |
| Visgeneer Inc. | 397.17 Million TWD | -235.781% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 64.629% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 38.23% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -51.019% |
| Neith Corporation | 192.15 Million TWD | -594.053% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 78.111% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1713.05% |
| Enimmune corporation | 604.82 Million TWD | -120.5% |
| TaiRx, Inc. | 833.74 Million TWD | -59.958% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 56.785% |
| EirGenix Inc. | 11.16 Billion TWD | 88.053% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -132.691% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 22.117% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 62.921% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -26.955% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -343.024% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -403.914% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -202.282% |
| RBC Bioscience Corporation | 753.79 Million TWD | -76.925% |
| BiOptic Inc. | 613.77 Million TWD | -117.286% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 25.02% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -14.997% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -106.815% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 57.066% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -801.512% |
| NaviFUS Corp. | 490.53 Million TWD | -171.875% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -8.805% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 2.181% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -152.037% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -14.832% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 19.48% |
| AP Biosciences Inc | 890.75 Million TWD | -49.72% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 84.36% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -311.43% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 50.807% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 91.32% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -225.074% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -236.056% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 35.757% |
| TCI GENE Inc. | 1.16 Billion TWD | -14.384% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -352.725% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 2.178% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -41.612% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -90.943% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 66.27% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 65.112% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -8.441% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 76.201% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -25.577% |
| Acepodia, Inc. | 6.81 Billion TWD | 80.441% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 65.147% |